Clinical trial
Study of Prophylactic Vs Preemptive Valganciclovir
NCT00374686 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00374686 |
|---|---|
| Title | Study of Prophylactic Vs Preemptive Valganciclovir |
| Official title | Prophylactic Vs Preemptive Oral Valganciclovir for Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients: A Clinical and Pharmacoeconomic Study |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cytomegalovirus Infection |
| Intervention type | Drug |
| Interventions | Valganciclovir |
| Enrollment | 120 |
| Start date | Mar 1, 2003 |
| Completion | Sep 1, 2005 |
| First posted | Sep 11, 2006 |
| Last update posted | Sep 11, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: